Baoyang Hu is a Principal Investigator at the Institute of Zoology, Chinese academy of Sciences (IOZ/CAS), known for his work in stem cell based neural regeneration and transplantation. He is the executive director of the Innovation Academy for Stem Cell and Regeneration of CAS, the deputy director of State Key Laboratory of Stem Cell and Reproductive Biology, and the executive dean of Medical School at the University of the CAS (UCAS).

Dr. Hu’s research interests focus on human brain development, neural differentiation and neural degenerative diseases. He pioneered the neural differentiation of subtype specific neurons from hESCs and discovered the variable neural differentiation potency of human iPSCs  (PNAS, 2010). Using hESC and neural differentiation as tool, his team discovered that SIRT6 represses H19 for proper development in primates, and knockout of SIRT6 cause development retardation of monkeys (Nature, 2018). He and his colleagues initiated the first clinical trial of treating Parkinson's disease using hESC-differentiated DA neuronal progenitors.

He has published more than 40 papers in prestigious journals such as Nature, Science, and Cell Stem Cells, and was granted two US patents. He serves as director of CSSCR and the Chinese Society of Cell Biology.